3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
2
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Squamous Intraepithelial Lesions
1
Papillomavirus Infections
1
HIV Infections
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Radiotherapy
138
Cyclophosphamide
108
Cisplatin
103
Doxorubicin
99
Vincristine
76
Filgrastim
60
Etoposide
58
Paclitaxel
56
Carboplatin
53
Fluorouracil
51
Methotrexate
49
Dexamethasone
49
Cytarabine
43
Prednisone
42
Leucovorin
40
Granulocyte Colony-Stimulating Factor
34
Docetaxel
34
Radiation
31
Specimen Handling
30
Tamoxifen
27
Daunorubicin
27
Magnetic Resonance Spectroscopy
26
Calcium Dobesilate
26
Ifosfamide
25
Mercaptopurine
24
Gemcitabine
24
Platinum
22
Goserelin
22
1,2-diaminocyclohexaneplatinum II citrate
22
Chemotherapy, Adjuvant
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
NETWORK
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts